MCT8 mutation analysis and identification of the first female with Allan-Herdon-Dudley syndrome due to loss of MCT8 expression

Department of Clinical Genetics, University Hospital azM Maastricht, Maastricht, The Netherlands.
European Journal of HumanGenetics (Impact Factor: 4.35). 04/2008; 16(9):1029-37. DOI: 10.1038/ejhg.2008.66
Source: PubMed


Mutations in the thyroid monocarboxylate transporter 8 gene (MCT8/SLC16A2) have been reported to result in X-linked mental retardation (XLMR) in patients with clinical features of the Allan-Herndon-Dudley syndrome (AHDS). We performed MCT8 mutation analysis including 13 XLMR families with LOD scores >2.0, 401 male MR sibships and 47 sporadic male patients with AHDS-like clinical features. One nonsense mutation (c.629insA) and two missense changes (c.1A>T and c.1673G>A) were identified. Consistent with previous reports on MCT8 missense changes, the patient with c.1673G>A showed elevated serum T3 level. The c.1A>T change in another patient affects a putative translation start codon, but the same change was present in his healthy brother. In addition normal serum T3 levels were present, suggesting that the c.1A>T (NM_006517) variation is not responsible for the MR phenotype but indicates that MCT8 translation likely starts with a methionine at position p.75. Moreover, we characterized a de novo translocation t(X;9)(q13.2;p24) in a female patient with full blown AHDS clinical features including elevated serum T3 levels. The MCT8 gene was disrupted at the X-breakpoint. A complete loss of MCT8 expression was observed in a fibroblast cell-line derived from this patient because of unfavorable nonrandom X-inactivation. Taken together, these data indicate that MCT8 mutations are not common in non-AHDS MR patients yet they support that elevated serum T3 levels can be indicative for AHDS and that AHDS clinical features can be present in female MCT8 mutation carriers whenever there is unfavorable nonrandom X-inactivation.

Download full-text


Available from: Ute Moog, Apr 10, 2014
  • Source
    • "Mutations in the colony-stimulating factor 1 receptor, CSF1R, previously implicated in tumor development, including myeloid and hematological malignancies (Ridge et al., 1990), have recently been identified in patients with HDLS, who reported having no bone-structure abnormalities (Rademakers et al., 2011); this suggests that CSF1R, which regulates the survival, proliferation, differentiation, and function of microglia in the brain (Stanley et al., 1997), may also be implicated in motor dysfunction. Likewise, SLC16A2 genetic variability, which was already implicated in X-linked mental retardation, Allan–Herndon–Dudley syndrome, and Pelizaeus–Merzbacher-like disease (Friesema et al., 2004; Dumitrescu et al., 2006; Frints et al., 2008; Vaurs-Barriere et al., 2009), has recently been associated with a X-linked form of leukoencephalopathy, clinically diagnosed as PMD (Tsurusaki et al., 2011). Although SLC16A2 encodes a thyroid hormone transporter known as monocarboxylate transporter 8, MCT8, none of PMD patients carrying SLC16A2 mutations reported thyroid dysfunction. "
    [Show abstract] [Hide abstract]
    ABSTRACT: New advances in genomic technology are being introduced at a greater speed and are revolutionizing the field of genetics for both complex and Mendelian diseases. For instance, during the past few years, genome-wide association studies (GWAS) have identified a large number of significant associations between genomic loci and movement disorders such as Parkinson's disease and progressive supranuclear palsy. GWAS are carried out through the use of high-throughput SNP genotyping arrays, which are also used to perform linkage analyses in families previously considered statistically underpowered for genetic analyses. In inherited movement disorders, using this latter technology, it has repeatedly been shown that mutations in a single gene can lead to different phenotypes, while the same clinical entity can be caused by mutations in different genes. This is being highlighted with the use of next-generation sequencing technologies and leads to the search for genes or genetic modifiers that contribute to the phenotypic expression of movement disorders. Establishing an accurate genome-epigenome-phenotype relationship is becoming a major challenge in the post-genomic research that should be facilitated through the implementation of both functional and cellular analyses.
    Full-text · Article · May 2012 · Frontiers in Genetics
  • Source
    • "MCT8 deficiency: This X-linked mental retardation syndrome in male subjects involves the transport of triiodothyronine into neurons with high T3 and inadequately low T4 and fT4 concentration [58]. This biological effect persists after complete thyroidectomy and substitution with levothyroxine, which involves peripheral deiodination. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Most inborn errors of metabolism (IEM) are recessive, genetically transmitted diseases and are classified into 3 main groups according to their mechanisms: cellular intoxication, energy deficiency, and defects of complex molecules. They can be associated with endocrine manifestations, which may be complications from a previously diagnosed IEM of childhood onset. More rarely, endocrinopathies can signal an IEM in adulthood, which should be suspected when an endocrine disorder is associated with multisystemic involvement (neurological, muscular, hepatic features, etc.). IEM can affect all glands, but diabetes mellitus, thyroid dysfunction and hypogonadism are the most frequent disorders. A single IEM can present with multiple endocrine dysfunctions, especially those involving energy deficiency (respiratory chain defects), and metal (hemochromatosis) and storage disorders (cystinosis). Non-autoimmune diabetes mellitus, thyroid dysfunction and/or goiter and sometimes hypoparathyroidism should steer the diagnosis towards a respiratory chain defect. Hypogonadotropic hypogonadism is frequent in haemochromatosis (often associated with diabetes), whereas primary hypogonadism is reported in Alström disease and cystinosis (both associated with diabetes, the latter also with thyroid dysfunction) and galactosemia. Hypogonadism is also frequent in X-linked adrenoleukodystrophy (with adrenal failure), congenital disorders of glycosylation, and Fabry and glycogen storage diseases (along with thyroid dysfunction in the first 3 and diabetes in the last). This is a new and growing field and is not yet very well recognized in adulthood despite its consequences on growth, bone metabolism and fertility. For this reason, physicians managing adult patients should be aware of these diagnoses.
    Full-text · Article · Jan 2012 · Orphanet Journal of Rare Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: Iterative feedback tuning (IFT) is a data-based method for the tuning of restricted complexity controllers. At each iteration, an update for the parameters of the controller is estimated from data obtained partly from the normal operation of the closed loop system and partly from a special experiment. The choice of a prefilter for the input data to the special experiment is a degree of freedom of the method. In the present contribution, the prefilter is designed in order to enhance the accuracy of the IFT update.
    No preview · Conference Paper · Jan 2004
Show more